Dr Rachael Morton

Senior Research Fellow
Public Health, School of Public Health

A27 - Edward Ford Building
The University of Sydney
NSW 2006 Australia

T: +61 2 9036 5459
F: +61 2 9351 5049
E:
W: Related website

Research interests

Health Economics

Economics of Kidney Disease

Melanoma

Economics of Surgery

Patient preferences for treatment in Chronic Kidney Disease

Discrete choice analysis

Teaching areas

Health economic evaluation

Cost-effectiveness analysis

Cancer clinical trials

Keywords

Nephrology; Surgery; Health economics; Melanoma and skin cancer

Publications

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009

2015

   
  • Watts, C., Cust, A., Menzies, S., Coates, E., Mann, G., Morton, R. (2015), Specialized Surveillance for Individuals at High Risk for Melanoma: A Cost Analysis of a High-Risk Clinic. JAMA Dermatology. 151(2), 178-186. [Abstract]
  • Watts, C., Dieng, M., Morton, R., Mann, G., Menzies, S., Cust, A. (2015), Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review. The British Journal of Dermatology. 172(1), 33-47. [Abstract]
  • Walker, R., Hanson, C., Palmer, S., Howard, K., Morton, R., Marshall, M., Tong, A. (2015), Patient and caregiver perspectives on home hemodialysis: a systematic review. American Journal of Kidney Diseases. 65(3), 451-463. [Abstract]

2014

   
  • Morton, R. (2014), Essential inputs for studies of cost-effectiveness analysis in melanoma. The British Journal of Dermatology. 171(6), 1294-1295. [Abstract]
  • Fortnum, D., Ludlow, M., Morton, R. (2014), Renal unit characteristics and patient education practices that predict a high prevalence of home-based dialysis in Australia. Nephrology (Carlton). 19(9), 587-593. [Abstract]
  • Foote, C., Morton, R., Jardine, M., Gallagher, M., Brown, M., Howard, K., Cass, A. (2014), COnsiderations of Nephrologists when SuggestIng Dialysis in Elderly patients with Renal failure (CONSIDER): a discrete choice experiment. Nephrology, Dialysis, Transplantation. 29(12), 2302-2309. [Abstract]
  • Wong, G., Howard, K., Webster, A., Morton, R., Chapman, J., Craig, J. (2014), How is Health Economics Relevant to Transplant Clinicians?. Transplantation. 98(2), 124-130. [Abstract]
  • Asha, S., Chan, A., Walter, E., Kelly, P., Morton, R., Ajami, A., Wilson, R., Honneyman, D. (2014), Impact from point-of-care devices on emergency department patient processing times compared with central laboratory testing of blood samples: a randomised controlled trial and cost-effectiveness analysis. Emergency Medicine Journal. 31(9), 714-719. [Abstract]
  • Walker, R., Marshall, M., Morton, R., McFarlane, P., Howard, K. (2014), The cost effectiveness of contemporary home haemodialysis modalities compared to facility haemodialysis: A systematic review of full economic evaluations. Nephrology. 19(8), 459-457. [Abstract]
  • Dieng, M., Watts, C., Kasparian, N., Morton, R., Mann, G., Cust, A. (2014), Improving subjective perception of personal cancer risk: systematic review and meta-analysis of educational interventions for people with cancer or at high risk of cancer. Psycho-Oncology. 23(6), 613-625. [Abstract]
  • Morton, R., Webster, A. (2014), Quality of Life in Chronic Kidney Disease. In: Management of Chronic Kidney Disease. (pp.487-500).Berlin: Springer.
  • Saw, R., Armstrong, B., Mason, R., Morton, R., Shannon, K., Spillane, A., Stretch, J., Thompson, J. (2014), Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D). BMC Cancer. 14, 780. [Abstract]

2013

   
  • Rychetnik, L., McCaffery, K., Morton, R., Thompson, J., Menzies, S., Irwig, L. (2013), Follow-up of early stage melanoma: Specialist clinician perspectives on the functions of follow-up and implications for extending follow-up intervals. Journal of Surgical Oncology. 107(5), 463-468. [Abstract]
  • Wyld, M., Clayton, P., Morton, R., Chadban, S. (2013), Anti-Coagulation, anti-platelets or no therapy in haemodialysis patients with atrial fibrillation: A decision analysis. Nephrology. 18(12), 783-789. [Abstract]
  • Rychetnik, L., McCaffery, K., Morton, R., Irwig, L. (2013), Psychosocial aspects of post-treatment follow-up for stage I/II melanoma: a systematic review of the literature. Psycho-Oncology. 22(4), 721-736. [Abstract]
  • Morton, R., Rychetnik, L., McCaffery, K., Thompson, J., Irwig, L. (2013), Patients' perspectives of long-term follow-up for localised cutaneous melanoma. European Journal of Surgical Oncology. 39(39), 297-303. [Abstract]
  • Brown, M., Urban, A., Sajiv, C., Glavish, R., May, S., Morton, R., Crail, S., Masterson, R., Foote, C., Robins, J., Katz, I., Stallworhty, E., Siva, B., Miller, C. (2013), ANZSN renal supportive care guidelines 2013: Research Issues in elderly patients: gaps in knowledge and suggested directions. Nephrology. 18(6), 439-441.
  • Merom, D., Cumming, R., Mathieu, E., Anstey, K., Rissel, C., Simpson, J., Morton, R., Cerin, E., Sherrington, C., Lord, S. (2013), Can social dancing prevent falls in older adults? a protocol of the Dance, Aging, Cognition, Economics (DAnCE) fall prevention randomised controlled trial. BMC Public Health. 13(1), 477. [Abstract]

2012

   
  • Wyld, M., Morton, R., Hayen, A., Howard, K., Webster, A. (2012), A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Medicine. 9(9), e1001307. [Abstract]
  • Morton, R., Snelling, P., Webster, A., Rose, J., Masterson, R., Johnson, D., Howard, K. (2012), Dialysis Modality Preference of Patients With CKD and Family Caregivers: A Discrete-Choice Study. American Journal of Kidney Diseases. 60(1), 102-111. [Abstract]
  • Morton, R., Snelling, P., Webster, A., Rose, J., Masterson, R., Johnson, D., Howard, K. (2012), Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. Canadian Medical Association Journal. 184(5), E277-E283. [Abstract]
  • Morton, R., Turner, R., Howard, K., Snelling, P., Webster, A. (2012), Patients Who Plan for Conservative Care Rather Than Dialysis: A National Observational Study in Australia. American Journal of Kidney Diseases. 59(3), 419-427. [Abstract]
  • Rychetnik, L., Morton, R., McCaffery, K., Thompson, J., Menzies, S., Irwig, L. (2012), Shared care in the follow-up of early-stage melanoma: a qualitative study of Australian melanoma clinicians' perspectives and models of care. BMC Health Services Research. 12, 468. [Abstract]

2011

   
  • Turner, R., Bell, K., Morton, R., Hayen, A., Francken, A., Howard, K., Armstrong, B., Thompson, J., Irwig, L. (2011), Optimizing the Frequency of Follow-Up Visits for Patients Treated for Localized Primary Cutaneous Melanoma. Journal of Clinical Oncology. 29(35), 4641-4646. [Abstract]
  • Morton, R., Tong, A., Webster, A., Snelling, P., Howard, K. (2011), Characteristics of dialysis important to patients and family caregivers: a mixed methods approach. Nephrology, Dialysis, Transplantation. 26(12), 4038-46. [Abstract]
  • Tong, A., Tjaden, L., Howard, K., Wong, G., Morton, R., Craig, J. (2011), Quality of Life of Adolescent Kidney Transplant Recipients. The Journal of Pediatrics. 159(4), 670-5.e2. [Abstract]
  • Tong, A., Morton, R., Howard, K., McTaggart, S., Craig, J. (2011), "When I had my transplant, I became normal." Adolescent perspectives on life after kidney transplantation. Pediatric Transplantation. 15(3), 285-293. [Abstract]
  • Morton, R., Howard, K., Webster, A., Snelling, P. (2011), Patient INformation about Options for Treatment (PINOT): a prospective national study of information given to incident CKD Stage 5 patients. Nephrology, Dialysis, Transplantation. 26(4), 1266-1274. [Abstract]
  • Fogarty, G., Morton, R., Vardy, J., Nowak, A., Mandel, C., Forder, P., Hong, A., Hruby, G., Burmeister, B., Shivalingam, B., Dhillon, H., Thompson, J. (2011), Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC cancer. 11(1), 142. [Abstract]

2010

   
  • Morton, R., Howard, K., Webster, A., Snelling, P. (2010), Patient information about options for treatment: Methods of a national audit of information provision in chronic kidney disease. Nephrology. 15(6), 649-652. [Abstract]
  • Morton, R., Devitt, J., Howard, K., Anderson, K., Snelling, P., Cass, A. (2010), Patient views about treatment of stage 5 CKD: a qualitative analysis of semistructured interviews. American Journal of Kidney Diseases. 55(3), 431-440. [Abstract]
  • Morton, R., Howard, K., Thompson, J. (2010), In Reply: Cost Effectiveness of Staging Procedures in Patients with Stage I/II Melanoma. Annals of Surgical Oncology. 17(2), 663-664. [Abstract]
  • Morton, R., Tong, A., Howard, K., Snelling, P., Webster, A. (2010), The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. BMJ. 340, c112. [Abstract]

2009

   
  • Thompson, J., Morton, R. (2009), In Reply: Cost-Effectiveness of Sentinel Node Biopsy for Melanoma. Annals of Surgical Oncology. 16(10), 2962-2963. [Abstract]
  • Tong, A., Morton, R., Howard, K., Craig, J. (2009), Adolescent Experiences Following Organ Transplantation: A Systematic Review of Qualitative Studies. Journal of Pediatrics. 155(4), 542-549. [Abstract]
  • Morton, R., Howard, K., Webster, A., Wong, G., Craig, J. (2009), The cost-effectiveness of induction immunosuppression in kidney transplantation. Nephrology, Dialysis, Transplantation. 24(7), 2258-2269. [Abstract]
  • Morton, R., Howard, K., Thompson, J. (2009), The Cost-Effectiveness of Sentinel Node Biopsy in Patients with Intermediate Thickness Primary Cutaneous Melanoma. Annals of Surgical Oncology. 16(4), 929-940. [Abstract]
  • Morton, R., Craig, J., Thompson, J. (2009), The Role of Surveillance Chest X-Rays in the Follow-Up of High-Risk Melanoma Patients. Annals of surgical oncology. 16(3), 571-7. [Abstract]
  • Morton, R., Moustakas, J., Howard, K., Webster, A., Snelling, P. (2009), A national audit of information provided to new CKD stage 4 & 5 patients: results from a pilot study. Renal Society of Australasia Journal. 5(3), 138-146.